Find news and press releases on SHRO discoveries, events, and other significant announcements.
PRESS RELEASES: 2011- 2005
SHRO RELEASE 2011
November 14, 2011
A compound that mimics the effects of adiponectin, a beneficial protein that is produced by fat tissue in healthy weight individuals and may exhibit protective effects against cancer, cardiovascular disease, inflammatory conditions and insulin resistance has been developed by an international consortium lead by Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University’s College of Science and Technology.
November 2, 2011
November 2 special public policy medical conference New Frontiers: An International Workshop Examining the Latest Research in Cancer Prevention sponsored by the Sbarro Health Research Organization and the National Italian American Foundation, was held on October 28th during the NIAF 36th Anniversary Gala Convention.
October 27, 2011
The Food and Drug Administration announced that they are pushing back its decision date to approve dapagliflozen, an experimental once-a-day drug to treat adults with Type 2 diabetes from AstraZeneca and Bristol-Myers Squibb, Bloomberg Business Week reports.
October 29, 2011
Dr. George Katter, a cardiologist who has dedicated a large part of his career to serving the sick and the poor Western Pennsylvania and in Haiti, will receive the second annual Giovan Giacomo Giordano Foundation and the National Italian American Foundation Award for Ethics and Creativity in Medical Research. Dr. Katter will be recognized at the National Italian American Foundations' 36th Anniversary Awards Convention Weekend, held October 28-29 at the Washington Hilton in Washington, D.C. Dr. Antonio Giordano, NIAF board member and President and Founder of the Sbarro Health Research Organization, will present the award.
October 5, 2011
The Sbarro Health Research Organization will be featured in a U.S. and Italian Research Start Up Showcase during U.S. & Italian Strategies for Turning Academic Research into Business -- An Italian Trade Commission International Seminar to Support U.S. -Italy Technology Transfer. The seminar will be held at the Cambridge Innovation Center on October 13-14th. Dr. Giuseppe Russo, research assistant professor and Director, Cancer Systems Biology and e-Health Programs for SHRO, will present SHRO as a case study of a successful international start up.
October 3, 2011
Cancer costs are rising at such a rapid rate that they threaten to become unsustainable even for rich countries, according to an expert panel assembled the The Lancet Oncology medical journal and reported by Bloomberg News.
September 27, 2011
Sbarro Health Research Organization and the Philadelphia and Delaware Valley branch of the Dominican Medical Collegiate will sponsor the 11th Dominican-American Medical Congress on the theme of Body, Mind and Health on September 30-October 2 at the Holiday Inn Hotel in Breinigsville, PA. The event will include a gala dinner and tours to historical sites in the Allentown area. For more information, call 215-291-9392 or 215-229-4357 or go to www.congreso.cmdfd.org.
September 10, 2011
A new study shows that firefighters who worked in the wreckage of the World Trade Center were 19 percent more likely to develop cancer than those who were not there, reports the New York Times. The study, which is the strongest evidence to date of a possible link between work at ground zero and cancer, was published in The Lancet.
September 1, 2011
Grad student David Mangani Rizzo defines Systems Biology
August 11, 2011
Sbarro Health Research Organization Biotechnology Research Center welcomed Archbishop Zygmunt Zimowki, the president for the Pontifical Council for Pastoral Care of Health Care Workers for the Catholic Church at the Vatican. Monsignor Zimowki is in charge of the church's global outreach for equitable health care.
July 25, 2011
Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors. Results appear in the journal Oncogene.
Salerno, Italy Honors Dr. Giordano
July 25, 2011
Congratulations to Antonio Giordano, M.D., PhD, the Director of the Sbarro Health Institute for Cancer Research and Molecular Medicine in Philadelphia, who on July 23rd received the prestigious Premio Salernitani illustri nel mondo prize for his professional contributions. The award was presented at the Palace St. Augustine in Salerno, Italy
July 7, 2011
A new report from the Sbarro Institute and the Human Health Foundation shows mounting scientific evidence that supports a significant increase in cancer mortality and malformations in specific areas of the Campania Region of Southern Italy, where improper waste management and illegal waste trafficking have been repeatedly documented. The study, Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy , was published in Cancer Biology & Therapy.
June 27, 2011
While many young people mistakenly believe that hand-rolled cigarettes are less dangerous to smoke than filtered cigarettes, a new study shows that smoking hand-rolled cigarettes has stronger genotoxic and oxidative effects on the metabolism than smoking manufactured filtered-cigarettes.
June 27, 2011
Cancer treatment is on the brink of a new era of genome based treatment, according to Dr. George Sledge, the outgoing president of ASCO. And the Sbarro Health Research Organization for Biotechnology Research is on the cutting edge of this revolution in genomic therapies.
Important New Skin Cancer Drug Approved
June 16, 2011
Michele Maio, a member of the scientific board of the Sbarro Health Research Organization (SHRO) and director of the Center for Cancer Immunotherapy of Siena, in collaboration with researchers from Human Health Onlus Foundation (HHF) of Spoleto, led the project Nibit M1, using for the first time Ipilimumab in combination with a chemotherapeutic agent (fotemustine) to combat cancer. Ipilimumab has recently been approved by the FDA for the treatment of skin cancer.
May 27, 2011
University City Science Center President & CEO Stephen S. Tang, Ph.D., MBA, highlighted the importance of the life sciences as an economic driver as he testified at a hearing of the U.S. Congress Joint Economic Committee on Wednesday, May 25, 2011 in Washington, DC.
Current Clinical Pathology
May 17, 2011
Humana Press link for Current Clinical Pathology Series, edited by Antonio Giordano, M.D., Ph.D. This series includes monographs dealing with important topics in surgical pathology, cytopathology hematology, and diagnostic laboratory medicine. It is aimed at practicing hospital based pathologists and their residents providing them with concise up-to- date reviews and state of the art summaries of current problems that these physicians may encounter in their daily practice of clinical pathology.
May 2, 2011
New long lasting insulin degludec may cut down on doses for Type-2 diabetics.
April 19, 2011
United States Congressman Mark S. Critz (D-PA) visited the Sbarro Health Research Organization for Biotechnology at the College of Science and Technology on the campus of Temple University. Expressing his strong support for funding biotechnology research, Rep. Critz toured the newly renovated SHRO facility with Dr. Antonio Giordano, the President and Founder of SHRO and the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Dr. Hai-Lung Dai, the Dean of the College of Science and Technology.
April 19, 2011
A new study sponsored by the Human Health Foundation and led by Umberto Galderisi, Associate Professor at the Department of Experimental Medicine, Second University of Naples and an adjunct professor at the Sbarro Institute in Philadelphia, USA, highlights the quality of certain vegetables, especially broccoli, in preserving the 'vitality' of stem cells.
April 13, 2011
Professor Miguel Forte described research into a new cell therapy for chronic inflammatory conditions such as Crohn's disease. Patient's own blood cells are used to produce a type of cell, Type 1 T regulatory lymphocyte,that can reduce the extent of the disease.
March 28, 2011
President and Founder of S.H.R.O is one of seven prestigious Italian-Americans, who have excelled in the fields of communication, business and medicine, to be elected to the Board of Directors of the National Italian American Foundation (NIAF).
March 5, 2011
A new study upends common beliefs about what makes for a long life.
March 4, 2011
A new study from the Sbarro Health Research Organization reveals new molecular insights into the understanding and treatment of Burkitt`s lymphoma.
February 24, 2011
New findings from SHRO reveal why the Rb2/p130 gene is expressed differently in small and non-small lung cancer cells.
February 16, 2011
Do we expect scientists always to be right? And have these expectations, along with a need to publish and be funded, led to an epidemic of problems with medical research? An insightful article, Lies, Damned Lies, and Medical Science examines these pressing issues.
February 9, 2011
House Appropriations Chairman Hal Rogers announced a partial list of 70 spending cuts that
will be included in an upcoming Continuing Resolution (CR) Bill that covers the remainder of government spending for fiscal
year (FY) 2011.
Cell Cycle Regulators/Inhibitors & Cancer
January 12, 2011
International Conference, Feb. 5-8, 2011, Vienna
For more information go toCnference
SHRO RELEASE 2010
December 10, 2010
Dr. Antonio Giordano, the director of the Sbarro Institute for Cancer Research and Molecular
Medicine and Chairman of the Scientific Advisory Committee for the Human Health Foundation, a nonprofit biomedical research
foundation in Italy, has voiced deep concerns about the actions of the Canadian government for its support of the asbestos industry.
December 7, 2010
The Autonomous University of Santo Domingo (UASD) has named Dr. Antonio Giordano, the Director of the Sbarro Institute for Cancer Research and Molecular Medicine, as an Honorary Professor in the Faculty of Health Sciences for his valuable contributions to research and the development of biomedicine.
November 9, 2010
A single injection of morphine to fight persistent pain in male rats strongly reduces the hormone testosterone in the brain and plasma, according to a new paper published in Molecular Pain. The study was led by Anna Maria Aloisi, M.D., of the Department of Physiology – Section of Neuroscience and Applied Physiology at the University of Siena, Italy, in collaboration with the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the University of Siena, and the Human Health Foundation in Spoleto, Italy.
October 20, 2010
On October 22nd, the Giovan Giacomo Giordano Foundation and the National Italian American Foundation (NIAF)(www.niaf.org) will jointly present the first Award for Ethics and Medical Creativity to Senator Prof. Ignazio R. Marino at the NIAF 35th anniversary gala at the Washington Hilton in Washington, D.C.The award honors the memory of Prof. Giovan Giacomo Giordano, a distinguished Italian medical oncologist and pathologist who devoted over 60 years of his life to the fields of cancer research and teaching.
October 18, 2010
Metabolic syndrome may be an indicator of breast cancer risk in post-menopausal women, according to a new study published by CROM (The Cancer Research Center in Mercogliano, Italy), the National Cancer Institute of Naples, Italy, and the Sbarro Health Research Organization, located at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy. Lead authors of the study were Immacolata Capasso, M.D. and Emanuela Esposito, M.D. both of the Department of Senology at the National Institute of Naples and Antonio Giordano, M.D., Ph.D., Director of the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA. Results of the study are online and will be published in the December issue of Cancer Biology and Therapy.
October 9, 2010
Join NIAF and the Sbarro Health Research Organization for a panel discussion on breast cancer on October 22nd during the 35th Gala of the National Italian American Foundation. Panelists include Dr. Antonio Giordano, Director of the Sbarro Institute for Molecular Medicine and Center for Biotechnology; Dr. Silvia Formenti, Chairman, NYU Dept. of Radiology; and Sen, Ignazio Marino, Investigative Committee on the National Healthcare System(Italian Senate).
October 5, 2010
On Friday, October 1, groundbreaking ceremonies were held for the new Beech International Apartments at Temple University, which will house the Sbarro Health Research Organization wing for international students and researchers.
Prestigious Award to Antonio Giordano
October 4, 2010
Antonio Giordano, M.D., Ph.D., Director of the Sbarro Institute for Cancer Research and Molecular Medicine and the Center for Biotechnology, was awarded the title of Commendatore, or Knight Commander, by the Republic of Italy on October 1st. The award was given for his important findings in cancer research. The awards are bestowed on "exemplary citizens who have shown respect for civic values and their work in the interest of common development.
September 26, 2010
Leptin may reduce the cytotoxicity of cAMP elevating agents and lead to new treatments for breast cancer. An interview with Dr. Silvio Naviglio of the Second University of Naples.
September 16, 2010
SHRO Scientific Advisory Board Member Michele Maio announces trials for promising new cancer treatment
September 7, 2010
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
August 31, 2010
The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation (HHF), a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy.
August 19, 2010
Cover Article on Cell Cycle Kinases by Silvia Lapenna & Antonio Giordano Draws High Citations and Recognition from Thomson-Reuters
'Big Ride' in Philly Benefits SHRO
August 10, 2010
August 2, 2010
Hospitals and patients wrestle over tumor tissue procurement, reports The Philadelphia Inquirer.
July 19, 2010
A Sbarro Institute and Istituto Superiore di Sanita, Rome, Italy study published in Endrocrine-Related Cancer shows that an increase in leptin, a cytokine that is normally increased in obese or overweight individuals, may promote colorectal neoplasms by activating colorectal cancer stem cells.
July 2, 2010
June 21, 2010
Distinguished clinician-researcher honored by SHRO for discoveries and service to community.
June 7, 2010
The Human Health Foundation (HHF), a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy opened its first bioscience laboratory for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy.
May 30, 2010
The U.S. Food and Drug Administration has approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.
May 30, 2010
The complex mechanisms and pathways behind genetic and epigenetic changes underpin the work of Marcella Macaluso, Ph.D., a research associate professor and Director of the Genetics & Epigenetics Program at the Sbarro Health Research Organization Center for Biotechnology
May 25, 2010
Naples conference to discuss prevention of HPV-related diseases
April 27, 2010
Eva Surmacz, Ph.D., associate professor in Biology at Temple University and the Director of the Obesity and Cancer Program at SHRO studies how the cytokine leptin can cause cancer and interfere with anti-cancer therapies.
April 27, 2010
Post-menopausal women who consume the most daily dietary fat had a 40 percent higher incidence of strokes compared with women who ate the least amount, according to research presented at the American Stroke Association International Stroke Conference 2010.
April 7, 2010
Src represents one of the most promising targets for cancer therapy. A new study by researchers from the Sbarro Health Research Center for Biotechnology and the Human Health Foundation (www.hhfonlus.org), shows that pyrazolo-[3,4-d]–pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma, a childhood brain cancer. The results were published in FASEB (The Journal of the Federation of American Societies for Experimental Biology).
March 22, 2010
New online forum puts pain treatment in the spotlight.
March 22, 2010
Investigating Novel Structure Proteins (NSPs) to locate new targets for cancer therapies
February 18, 2010
Altering gravitational forces may speed the growth and repair of tissues at the cellular level, according to research completed by Andrew Puca, Ph.D., of the Sbarro Health Research Organization Center for Biotechnology Research.
February 17, 2010
A new study funded by the College of Health Professions and Social Work Interdisciplinary Research Fund at Temple University will pair the biotechnology skills of Dr. Giuseppe Russo, a research assistant professor and director of e-Health and Cancer Systems Biology programs at the Sbarro Health Research Organization Center for Biotechnology Research in the College of Science & Technology and the weight loss expertise of Dr. Melissa Napolitano, an associate professor at the Center for Obesity Research and Education (CORE) and Departments of Kinesiology and Public Health to find out.
Chronic Dry Eyes Can Be Helped
February 5, 2010
Dr. Mina Massaro-Giordano, an associate professor at the University of Pennsylvania and co-director of the Penn Dry Eye & Ocular Center, explains the problem of dry eyes and the newest therapies..
January 22, 2010
Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the Human Health Foundation in Spoleto, Italy have found that MECP2, a gene that modifies the chromatin in the cell, has important role in stem cell aging.
January 20, 2010
Researchers working at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have found that the downregulation, or reduction, of the tumor suppressor gene 16INK4A may be a novel marker of the heritable susceptibility for the disease. The study appears in the Journal of Cellular Physiology.
January 20, 2010
Glaucoma, a group of eye diseases that damage the optic nerve and destroy eyesight, affects close to four million Americans, although half are not aware that they have it. Worldwide, the World Health Organization reports that glaucoma is the primary cause of blindness for about 4.5 million people With its painless and gradual loss of vision, glaucoma may have no early warning signs, but it can be detected during a comprehensive dilated eye exam.
SHRO RELEASE 2009
November 20, 2009
According to the Italian news agency ANSA, as of November 19th, 75 Italians have died from H1N1, with 28 from the Campania region of Naples.Giulio Tarro, M.D., the Chief Physician of Virology at Cotugno Hospital of Naples and an adjunct professor at Temple University of Philadelphia discusses the impact, treatment and future of the flu epidemic.
SHRO Research on Stem Cells Recognized
November 20, 2009
Research by Umberto Galderisi and Antonio Giordano on the effect of stem cells in the treatment of arterial stenosis will be published as part of the proceedings of the prestigious 5th International Conference on Mesenchymal and Non-Hematopoietic Stem Cells (MSCs) at Texas A & M Health Science Center College of Medicine.
November 15, 2009
The award cites the quality of his work, "attested to by the fact that it provides an impetus for other investigators studying cancer growth control and it has resulted in a framework for our conceptualization of cancer development and mechanisms of tumor suppression."
November 3, 2009
Dr. Ang Sun, who studied for six years for his Ph.D. under the guidance of Antonio Giordano, M.D., Ph.D., the Founder and President of the Sbarro Health Research Organization, has been awarded the 2009 Award for Outstanding Research by a Graduate Student from the College of Science and Technology at Temple University.
October 27, 2009
The Sbarro Health Research Organization, a nonprofit research facility located at Temple University, dedicated a new state-of-the-art biotechnology research center on October 27th. SHRO has been ranked as one of the top three international laboratories based on number of publications as ranked by the Cell Cycle Registry.
October 18, 2009
The Sbarro Health Research Organization,will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m.
A host of dignitaries will join guests and researchers at the dedication ceremony, including Pennsylvania Representatives the Honorable Sam Smith and Mario J. Civera , Jr. Also in attendance will be His Eminence Cardinal Justin Rigali, Archbishop of Philadelphia, Ann Weaver Hart, the President of Temple University, and Hai-Lung Dai, Ph.D., the Dean of Temple University’s College of Science and Technology.
October 5, 2009
CSHL graduate Antonio Giordano remembers Carol Greider, 2009 Nobel Prize Winner in Medicine.
October 2, 2009
Few Americans know the truth about mesothelioma, a deadly and incurable cancer cauesd by exposure to asbestos. Heavy and widespread use of asbestos through most of the last century, coupled with a 20-50 year latency in tumor development, make mesothelioma today a lethal threat to tens of millions of Americans. Yet, the U.S. has ignored the need for research to develop effective treaments, and still has not even banned asbestos.
September 27, 2009
September 24, 2009
President and Founder of SHRO receives the prestigious prize from The American University of Rome, in recognition of his work to promote economic and scientific cooperation between Italy and the United States.
August 28, 2009
Bidding starts at $25,000 (it's tax-deductible!) to get Your Name (or your loved one's or your company's) on a fellowship to be awarded by the Philadelphia and Siena Italy-based Sbarro Health Research Organization. Place your bid on E-Bay by clicking here !
August 18, 2009
If it is summer in the city, that means that high school interns are hard at work in the Sbarro Institute laboratories located at Temple University in Philadelphia. This year, the Institute hosted three high school juniors, who worked closely with Sbarro Institute post-doctorate fellows Marco Cassone, M.D., Ph.D. and Valentina Caracciolo, Ph.D. and Annalisa Roberti, a Ph.D student.
Antonio Giordano, M.D., Ph.D.: A War We Must Win
Neuronal Guidance Molecule May Lead to Future Treatments for Human Embryonal Carcinoma
Students Visit SHROs Digilab:
Cell Cycle Kinases as Therapeutic Targets for Cancer:
Antonio Giordano, M.D., Ph.D. Places Third on List of "Laboratory Heads by Number of Publications"
Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported: June 29, 2009
Italy Welcomes New Public Health TV Channel
Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments
Gene Marker May Improve Odds on Stem Cell Therapies for Disease
With an Eye To Italy
SHRO RELEASE 2008
Sbarro Health Research Organization researcher Dr. Letizia Cito of the CROM Institute, Mercogliano (AV, Italy) delivered a virtual lecture on "Cancer, Cell Cycle, and Check Points" as an invited guest to a scientific meeting sponsored by the University of Barcelona, Spain. Dr. Cito's lecture took place on The Learning Experience Main Campus in Second Life. View the lectures: Part-1 Part-2
New hope for combating HIV, the virus that leads to AIDS. The Laboratory of Pharmaceutical Chemistry, University of Siena, led by Professor Maurizio Botta, an Adjunct Professor at SHRO, took part to this research.
Nature Clinical Practice Cardiovascular Medicine: September, 2008, Vol.8, No.9
Stem cell niches as clinical targets: the future of anti-ischemic therapy? Editorial on possible clinical impact of research conducted by an international collaboration of scientists directed by Sbarro Institute Professor Claudio Napoli, M.D., Ph.D.
Sbarro Institute Professor Claudio Napoli, M.D., Ph.D. Directs International Collaboration on Therapeutic Targeting of the Stem Cell Niche in Experimental Hindlimb Ischemia published in Nature Clinical Practice Cardiovascular Medicine
Report on tour of Biomedical Research Labs Island in the company of Prof. Giuseppe Russo (sl name Alfa Roux) , the owner of the sim and CEO of Digi S Lab
SHRO Scores on Second Life: Linden Labs Cites SHRO Platform as Model for Other Health and Wellness Nonprofit Organizations
SHRO Opens Internet Center on Futuristic Second Life
Developmental Biologist Gianfranco Bellipanni, Ph.D. Joins Faculty of the Sbarro Intstitute.
International Team Reveals First Prognosticator of Survival in Aggressive Cancer
Summer Science at Sbarro Institute: International program mentors college and high school students for 15th year
Anna Rita Fioroni, Senator of the Democratic Party (PD) in Italy, recently paid a visit to the Sbarro Health Research Organization (SHRO) in Philadelphia
SHRO Fellow Mario Federico, M.D., publishes chapter on brachytherapy in Principles and Practice of Radiation Oncology, the most widely used textbook on radiation oncology.
Protein Cdk9-55 May Induce Muscle Regeneration in Damaged and Healthy Tissues
Cdk9-55: A New Player in Muscle Regeneration
Professor Claudio Napoli: Novel Approach May Spell Safer Gene Therapy
SHRO Release: Jan 11, 2008
SHRO RELEASE 2007
SHRO RELEASE 2006
SHRO RELEASE 2005
© Copyright 2003 - 2010, Sbarro Health Research Organization,All rights reserved.